Hospital-acquired infection is of increasing concern in the health service, and the spectre of MRSA is now being joined by other, equally problematic infections. However, new technology from Acolyte Biomedica has joined the fight and promises to expedite detection and antibiotic susceptibility testing, directly from clinical specimens.
Log in or register FREE to read the rest
This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text.
If you don't already have an account, please register with us completely free of charge.